Autism drug ML-004 moves to safety check in teens and adults
NCT ID NCT05889273
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 31 times
Summary
This study is checking the safety of a drug called ML-004 in about 120 people aged 12 to 46 with autism. All participants have already completed an earlier study of the same drug. The main goal is to see what side effects occur, and the study is open-label, meaning everyone knows they are getting the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APG Research, LLC
Orlando, Florida, 32803, United States
-
Abba Medical Group
Miami, Florida, 33176, United States
-
BioBehavioral Research of Austin
Austin, Texas, 78759, United States
-
Brain and Mind Centre
Camperdown, New South Wales, 2050, Australia
-
Cortica
San Rafael, California, 94903, United States
-
Cortica Healthcare
Glendale, California, 91203, United States
-
Family Psychiatry of The Woodlands
The Woodlands, Texas, 77381, United States
-
Harmonex Neuroscience Research
Dothan, Alabama, 36303, United States
-
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, M4G 1R8, Canada
-
NRC Research Institute
Orange, California, 92868, United States
-
Nathan Kline Institute for Psychiatric Research
Orangeburg, New York, 10962, United States
-
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan, 48302, United States
-
Richmond Behavioral Associates
Staten Island, New York, 10314, United States
-
Road Runner Research, Ltd.
San Antonio, Texas, 78249, United States
-
Southwest Autism Research and Resource Center
Phoenix, Arizona, 85006, United States
-
Suburban Research Associates
Media, Pennsylvania, 19063, United States
-
The Children's Research Institute
Washington D.C., District of Columbia, 20010, United States
-
The Royal Children's Hospital, Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
-
University of Missouri, Thompson Center for Autism & Neurodevelopment
Columbia, Missouri, 65211, United States
-
University of South Florida Psychiatry and Behavioral Neurosciences
Tampa, Florida, 33613, United States
-
Yale Child Study Center
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.